Henry Cheng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Henry Cheng

Showing results (21-30 of 25) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 25 results.

Pediatric Cardiology|May 13, 2019

Early Neurodevelopmental Outcomes in Children Supported with ECMO for Cardiac IndicationsAnjali Sadhwani, Henry Cheng, Christian Stopp, et al.

The Journal of Thoracic and Cardiovascular Surgery|October 2, 2007

B-type natriuretic peptide levels predict outcome after neonatal cardiac surgeryJong-Hau Hsu, Roberta L Keller, Omar Chikovani, et al.

Journal of the American Heart Association|May 21, 2013

Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heartShiraj Sen, Bijoy K Kundu, Henry Cheng-Ju Wu, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|November 20, 2012

Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formationNicholas J Leeper, Azad Raiesdana, Yoko Kojima, et al.

Bioorganic & Medicinal Chemistry Letters|December 20, 2003

Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridineJin Li, Kristin M Lundy DeMello, Henry Cheng, et al.

Pageof 3

Search research articles

Showing results (21-30 of 25) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 25 results.

Pediatric Cardiology|May 13, 2019

Early Neurodevelopmental Outcomes in Children Supported with ECMO for Cardiac IndicationsAnjali Sadhwani, Henry Cheng, Christian Stopp, et al.

The Journal of Thoracic and Cardiovascular Surgery|October 2, 2007

B-type natriuretic peptide levels predict outcome after neonatal cardiac surgeryJong-Hau Hsu, Roberta L Keller, Omar Chikovani, et al.

Journal of the American Heart Association|May 21, 2013

Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heartShiraj Sen, Bijoy K Kundu, Henry Cheng-Ju Wu, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|November 20, 2012

Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formationNicholas J Leeper, Azad Raiesdana, Yoko Kojima, et al.

Bioorganic & Medicinal Chemistry Letters|December 20, 2003

Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridineJin Li, Kristin M Lundy DeMello, Henry Cheng, et al.

Pageof 3